Despite 10 Percent Decline in Q1 Revenues, Waters CEO Sees Rays of Light for Second Half of 2009 | GenomeWeb

This story originally ran on April 28.

In the midst of reporting a 10 percent drop in revenues for the first quarter, Waters officials sounded a guarded note that the second half of 2009 could hold reasons for hope.

This week, Waters said that revenues for the three months ended April 4 fell to $333 million from $372 million during Q1 2008. Currency translation contributed 5 percentage points of the total drop in revenues.

Instrument sales were down by 16 percent in the quarter, while consumables and services rose 9 percent.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.